FXYD3: A Key Regulator of Ion Homeostasis and Redox Balance in Cancer Biology

Megha Gupta1, Satyanarayan Rao1, Rajesh Kumar1

  • 1Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, India.

Current Drug Targets
|June 17, 2026
PubMed

Insights

FXYD3, a transmembrane protein, drives cancer progression and therapy resistance by regulating ion balance and signaling pathways. Targeting FXYD3 shows potential for novel cancer diagnostics and therapeutics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer metastasis is a leading cause of mortality.
  • Transmembrane protein disruption significantly impacts tumor development.
  • FXYD3 regulates key cellular processes including ion balance and signaling.

Purpose of the Study:

  • To review the role of FXYD3 in cancer biology.
  • To highlight FXYD3's potential as a biomarker and therapeutic target.

Main Methods:

  • Literature review of FXYD3's function in various cancers.
  • Analysis of FXYD3's involvement in signaling pathways (e.g., PI3K-AKT, cGMP-PKG).
  • Examination of FXYD3's role in cellular processes like oxidative stress response and apoptosis.

Main Results:

  • FXYD3 expression varies across multiple cancer types (breast, pancreatic, lung, etc.).
  • FXYD3 is implicated in tumor development, therapy resistance, and immune modulation.
  • FXYD3 promotes cell survival by protecting against oxidative stress and inhibiting apoptosis.

Conclusions:

  • FXYD3 is a significant regulator of cancer cell malignancy and survival.
  • FXYD3 holds promise as a diagnostic and prognostic biomarker.
  • Targeting FXYD3 presents a potential therapeutic strategy for cancer treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
pH Regulation in Cells01:28

pH Regulation in Cells

pH plays a critical role in maintaining normal cellular activities. It helps maintain the structure and function of various proteins, dictates the charge on cellular membranes, and is crucial for metabolic reactions inside the cell. Moreover, cells use the energy from the proton motive force to generate ATP.
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...